Substance Use Disorder

This APSARD 2024 conference poster finds that individuals with ADHD have distinct motivations and patterns of substance use.

Regular THC use in adolescence is not a benign activity—it can have life-changing consequences. Here’s what you need to know.

From substance use disorders in physicians to new research on the efficacy of MDMA-assisted therapy for PTSD, here are highlights from the week in Psychiatric Times.

What is new in research on posttraumatic stress disorder?

What is new in research on schizophrenia?

What neuromodulation can be used to specifically target nicotine users with schizophrenia? This research may tell us.

In this CME, review the risks and clinical implications of intimate partner violence on women’s substance use and treatment.

Young men appear to be particularly susceptible to the effects of cannabis on schizophrenia.

What is new in research on SUDs?

Explore the relationship between cannabis use and psychosis.

The FDA has released a draft guide to offer their perspective and thoughts on the development of treatments for stimulant use disorder.

From violence risk assessment in emergency departments to connections between bipolar disorder and substance use disorders, here are highlights from the week in Psychiatric Times.

An expert discusses the connections between the 2 highly comorbid diseases and some ways to effectively treat both diseases simultaneously.

Today is International Overdose Awareness Day!

“We expect this antibody to be a valuable new weapon for fighting the opioid crisis.”

The experts weighed in on a wide variety of psychiatric issues for the July 2023 issue of Psychiatric Times.

From a look at adolescent substance use to special challenges in treating borderline personality disorder during the perinatal period, here are highlights from the week in Psychiatric Times.

"Although adolescent substance use is a topic that can be challenging for families and clinicians alike, data demonstrate that interventions during this time are effective for preventing, identifying, and reducing risky use."

How can we turn the tide of the fentanyl epidemic?

Should cannabis be regulated in the United States in a manner similar to alcohol and tobacco?

From adherence in addiction recovery treatment to the relationship between social media use and youth mental health, here are highlights from the week in Psychiatric Times.

Here’s how you can effectively encourage treatment adherence when helping patients with substance use disorder.

From substance use among adolescents and young adults to managing behavioral and psychological symptoms of dementia, here are highlights from the week in Psychiatric Times.

In this CME, check out best practices for screening and treating adolescents and young adults with substance use issues.

"It is essential to have an aggressive path forward to increase public awareness of mental health and illness, education on early intervention and treatment access, and continued destigmatization of mental illness."

Ketamine is relatively new to the average American. What can you share with them as a mental health clinician?

From new FDA treatment approvals to choosing the right levels of care in crisis stabilization units, here are highlights from the week in Psychiatric Times.

Here’s how having a clear understanding of the services different crisis stabilization units provide can help communities serve the unique needs of each individual in crisis without unnecessarily restrictive or intensive levels of care.

The experts weighed in on a wide variety of psychiatric issues for the April 2023 issue of Psychiatric Times.